000			03678nam a22005897a 4500
008			201231s20202020 xxu||||| |||| 00| 0 eng d
022			_a1080-6032
024			_a10.1016/j.wem.2020.08.001 [doi]
024			_aS1080-6032(20)30131-9 [pii]
040			_aOvid MEDLINE(R)
099			_a33168403
245			_aMorbidity Among Athletes Presenting for Medical Care During 3 Iterations of an Ultratrail Race in the Himalayas.
251			_aWilderness & Environmental Medicine. 31(4):437-440, 2020 Dec.
252			_aWilderness Environ Med. 31(4):437-440, 2020 Dec.
252			_zWilderness Environ Med. 31(4):437-440, 2020 Dec.
253			_aWilderness & environmental medicine
260			_c2020
260			_fFY2021
265			_sppublish
265			_sppublish
266			_d2020-12-31
268			_aWilderness & Environmental Medicine. 31(4):437-440, 2020 Dec.
501			_aAvailable online from MWHC library: 1995 - present
520			_aCONCLUSIONS: Ultratrail races at high altitude pose a challenge in terms of provision of medical care in a remote setting with limited resources. However, most of the illnesses are minor in nature and easily managed by the race doctor. Knowledge of common illnesses among travelers to the area can help aid in preparation and provision of proper care, especially in remote settings with limited resources. Copyright (c) 2020 Wilderness Medical Society. Published by Elsevier Inc. All rights reserved.
520			_aINTRODUCTION: Although ultratrail races are increasing in popularity, there is a dearth of data regarding illnesses and medical care at these events. Data about injuries and illnesses for races taking place in the Himalayas, where the nearest medical facility can be hundreds of miles away, are even harder to find. This study aimed to describe the injuries and illnesses befalling the participants of a 7-stage 212 km (132 mi) trail race at high altitude.
520			_aMETHODS: Ethical approval was obtained from Nepal Research Health Council. A retrospective study of the record of medical encounters among the 100 participants competing in the Manaslu trail race in Nepal from 2014 to 2016 was performed. Diagnoses were classified into various categories. Informed consent was taken from all participants.
520			_aRESULTS: Acute diarrhea was the most common ailment reported among the participants (18%), followed closely by musculoskeletal problems (17%). Altitude illness made up 6% of care provided. Approximately 35% of the athletes were using acetazolamide as prophylaxis for high altitude illnesses. The 1 case needing evacuation in the 3 iterations was high altitude pulmonary edema.
546			_aEnglish
650			_a*Altitude Sickness/di [Diagnosis]
650			_a*Athletic Injuries
650			_a*Marathon Running/in [Injuries]
650			_aAcetazolamide/ad [Administration & Dosage]
650			_aAcetazolamide/pd [Pharmacology]
650			_aAdult
650			_aAltitude
650			_aAltitude Sickness/pc [Prevention & Control]
650			_aAltitude Sickness/th [Therapy]
650			_aCarbonic Anhydrase Inhibitors/ad [Administration & Dosage]
650			_aCarbonic Anhydrase Inhibitors/pd [Pharmacology]
650			_aDiarrhea
650			_aFemale
650			_aHumans
650			_aHypertension, Pulmonary
650			_aMale
650			_aNepal
651			_aMedStar Union Memorial Hospital
657			_aJournal Article
700			_aSubedi, Yogesh
790			_aBasyal B, Dawadi S, Subedi Y
856			_uhttps://dx.doi.org/10.1016/j.wem.2020.08.001 _zhttps://dx.doi.org/10.1016/j.wem.2020.08.001
942			_cART _dArticle
999			_c5990 _d5990